Cardiovascular outcomes in children with Kawasaki disease: a population-based cohort study

Burgner, D. & Harnden, A. Kawasaki disease: what is the epidemiology telling us about the etiology? Int J. Infect. Dis. 9, 185–194 (2005).

PubMed  PubMed Central  Google Scholar 

Singh, S., Vignesh, P. & Burgner, D. The epidemiology of Kawasaki disease: a global update. Arch. Dis. Child 100, 1084–1088 (2015).

PubMed  Google Scholar 

Robinson, C. et al. Incidence and short-term outcomes of Kawasaki disease. Pediatr. Res. 90, 670–677. https://doi.org/10.1038/s41390-021-01496-5 (2021).

McCrindle, B. W. et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135, e927–e999 (2017).

PubMed  Google Scholar 

Taubert, K. A. Epidemiology of Kawasaki disease in the United States and worldwide. Prog. Pediatr. Cardiol. 6, 181–185 (1997).

Google Scholar 

Holman, R. C., Curns, A. T., Belay, E. D., Steiner, C. A. & Schonberger, L. B. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 112, 495–501 (2003).

PubMed  Google Scholar 

Oates-Whitehead, R. M. et al. Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst. Rev. 2003, CD004000. https://doi.org/10.1002/14651858.CD004000 (2003).

Orenstein, J. M. et al. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One 7, e38998 (2012).

PubMed  PubMed Central  Google Scholar 

Burns, J. C. & Glodé, M. P. Kawasaki syndrome. Lancet Lond. Engl. 364, 533–544 (2004).

Google Scholar 

Naoe, S., Takahashi, K., Masuda, H. & Tanaka, N. Kawasaki disease. With particular emphasis on arterial lesions. Acta Pathol. Jpn 41, 785–797 (1991).

PubMed  Google Scholar 

Kato, H. et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94, 1379–1385 (1996).

PubMed  Google Scholar 

Bang, J. S. et al. Long-term prognosis for patients with Kawasaki disease complicated by large coronary aneurysm (diameter ≥ 6 mm). Korean Circ. J. 47, 516–522 (2017).

PubMed  PubMed Central  Google Scholar 

Tsuda, E. et al. A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease. Am. Heart J. 167, 249–258 (2014).

PubMed  Google Scholar 

McNeal-Davidson, A. et al. The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the Province of Quebec: the complete series since 1976. Pediatr. Cardiol. 34, 170–178 (2013).

PubMed  Google Scholar 

Friedman, K. G. et al. Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J. Am. Heart Assoc. 5, e003289. https://doi.org/10.1161/JAHA.116.003289 (2016).

Holve, T. J. et al. Long-term cardiovascular outcomes in survivors of Kawasaki disease. Pediatrics 133, e305–e311 (2014).

PubMed  Google Scholar 

Miura, M. et al. Association of severity of coronary artery aneurysms in patients with Kawasaki disease and risk of later coronary events. JAMA Pediatr. 172, e180030 (2018).

PubMed  PubMed Central  Google Scholar 

McCrindle, B. W. et al. Medium‐term complications associated with coronary artery aneurysms after Kawasaki disease: a study from the International Kawasaki Disease Registry. J. Am. Heart. Assoc. 9, e016440.https://doi.org/10.1161/JAHA.119.016440 (2020).

Suda, K. et al. Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: a single-institution experience. Circulation 123, 1836–1842 (2011).

PubMed  Google Scholar 

Cheung, Y. F., Yung, T. C., Tam, S. C. F., Ho, M. H. K. & Chau, A. K. T. Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis. J. Am. Coll. Cardiol. 43, 120–124 (2004).

PubMed  Google Scholar 

Gupta-Malhotra, M. et al. Atherosclerosis in survivors of Kawasaki disease. J. Pediatr. 155, 572–577 (2009).

PubMed  Google Scholar 

Dietz, S. M., Tacke, C. E. A., Hutten, B. A. & Kuijpers, T. W. Peripheral endothelial (dys)function, arterial stiffness and carotid intima-media thickness in patients after Kawasaki disease: a systematic review and meta-analyses. PLoS One 10, e0130913 (2015).

PubMed  PubMed Central  Google Scholar 

National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 128, S213–S256 (2011).

Google Scholar 

Gordon, J. B., Kahn, A. M. & Burns, J. C. When children with Kawasaki disease grow up: myocardial and vascular complications in adulthood. J. Am. Coll. Cardiol. 54, 1911–1920 (2009).

PubMed  PubMed Central  Google Scholar 

McCrindle, B. W., McIntyre, S., Kim, C., Lin, T. & Adeli, K. Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis? J. Pediatr. 151, 244–248 (2007).

PubMed  Google Scholar 

Banks, L. et al. Factors associated with low moderate-to-vigorous physical activity levels in pediatric patients with Kawasaki disease. Clin. Pediatr. (Philos.) 51, 828–834 (2012).

Google Scholar 

Baker, A. L. et al. Physical and psychosocial health in children who have had Kawasaki disease. Pediatrics 111, 579–583 (2003).

PubMed  Google Scholar 

Statistics Canada. Ontario [Province] and Canada [Country] (Table). Census Profile. 2016 Census. Statistics Canada; 2017. Accessed December 10, 2019. https://www12.statcan.gc.ca/census-recensement/2016/dp-pd/prof/index.cfm?Lang=E.

von Elm, E. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet Lond. Engl. 370, 1453–1457 (2007).

Google Scholar 

Benchimol, E. I. et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement. PLoS Med. 12, e1001885 (2015).

PubMed  PubMed Central  Google Scholar 

Manlhiot, C. et al. Epidemiology of Kawasaki disease in Canada 2004 to 2014: comparison of surveillance using administrative data vs periodic medical record review. Can. J. Cardiol. 34, 303–309 (2018).

PubMed  Google Scholar 

Patel, T. et al. Endpoints in diabetes cardiovascular outcome trials. Lancet 391, 2412 (2018).

PubMed  Google Scholar 

Miao, B. et al. Incidence and predictors of major adverse cardiovascular events in patients with established atherosclerotic disease or multiple risk factors. J. Am. Heart Assoc. 9, e014402. https://doi.org/10.1161/JAHA.119.014402 (2020).

Lim, W. H. et al. Impact of pretransplant and new-onset diabetes after transplantation on the risk of major adverse cardiovascular events in kidney transplant recipients: a population-based cohort study. Transplantation 105, 2470–2481 (2021).

PubMed  Google Scholar 

Hussain, M. A. et al. Association between statin use and cardiovascular events after carotid artery revascularization. J. Am. Heart Assoc. 7, e009745 (2018).

PubMed  PubMed Central  Google Scholar 

Sud, M. et al. Association between adherence to fractional flow reserve treatment thresholds and major adverse cardiac events in patients with coronary artery disease. JAMA 324, 2406 (2020).

PubMed  Google Scholar 

McCormick, N., Bhole, V., Lacaille, D. & Avina-Zubieta, J. A. Validity of diagnostic codes for acute stroke in administrative databases: a systematic review. PLoS One 10, e0135834 (2015).

PubMed  PubMed Central  Google Scholar 

McCormick, N., Lacaille, D., Bhole, V. & Avina-Zubieta, J. A. Validity of myocardial infarction diagnoses in administrative databases: a systematic review. PLoS One 9, e92286 (2014).

PubMed  PubMed Central  Google Scholar 

Canadian Institute for Health Information (CIHI). Health Indicators 2013. Canadian Institute for Health Information; 2013. Accessed December 18, 2019. https://secure.cihi.ca/free_products/HI2013_EN.pdf.

Shah, B. R. et al. Surname lists to identify South Asian and Chinese ethnicity from secondary data in Ontario, Canada: a validation study. BMC Med. Res. Methodol. 10, 42. https://doi.org/10.1186/1471-2288-10-42 (2010).

Simon, T. D., Haaland, W., Hawley, K., Lambka, K. & Mangione-Smith, R. Development and validation of the Pediatric Medical Complexity Algorithm (PMCA) Version 3.0. Acad. Pediatr. 18, 577–580 (2018).

PubMed  PubMed Central  Google Scholar 

Lin, M. T. et al. Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous γ-immunoglobulin therapy. Arch. Dis. Child 100, 542–547 (2015).

PubMed  Google Scholar 

Nakamura, Y. et al. Mortality among Japanese with a history of Kawasaki disease: results at the end of 2009. J. Epidemiol. 23, 429–434 (2013).

PubMed  Google Scholar 

Nakamura, Y., Yanagawa, H., Harada, K., Kato, H. & Kawasaki, T. Mortality among persons with a history of Kawasaki disease in Japan: the fifth look. Arch. Pediatr. Adolesc. Med. 156, 162 (2002).

PubMed  Google Scholar 

Carlton-Conway, D. et al. Behaviour sequelae following acute Kawasaki disease. BMC Pediatr. 5, 14 (2005).

PubMed  PubMed Central  Google Scholar 

Kourtidou, S. et al. Kawasaki disease substantially impacts health-related quality of life. J. Pediatr. 193, 155–163.e5 (2018).

PubMed  Google Scholar 

Printz, B. F. et al. Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. J. Am. Coll. Cardiol. 57, 86–92 (2011).

PubMed  PubMed Central  Google Scholar 

Moran, A. M. et al. Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. Am. Heart J. 139, 217–223 (2000).

PubMed  Google Scholar 

Yonesaka, S. et al. Histopathological study on Kawasaki disease with special reference to the relation between the myocardial sequelae and regional wall motion abnormalities of the left ventricle. Jpn Circ. J. 56, 352–358 (1992).

PubMed  Google Scholar 

Tsuda, E. et al. The 30-year outcome for patients after myocardial infarction due to coronary artery lesions caused by Kawasaki disease. Pediatr. Cardiol. 32, 176–182 (2011).

PubMed  Google Scholar 

Hirata, S., Nakamura, Y., Matsumoto, K. & Yanagawa, H. Long-term consequences of Kawasaki disease among first-year junior high school students. Arch. Pediatr. Adolesc. Med. 156, 77 (2002).

PubMed  Google Scholar 

Yeom, J. S., Cho, J. Y. & Woo, H. O. Understanding the importance of cerebrovascular involvement in Kawasaki disease. Korean J. Pediatr. 62, 334–339 (2019).

PubMed  PubMed Central  Google Scholar 

Ichiyama, T. et al. Cerebral hypoperfusion during acute Kawasaki disease. Stroke 29, 1320–1321 (1998).

PubMed  Google Scholar 

Amano, S. & Hazama, F. Neutral involvement in kawasaki disease. Acta Pathol. Jpn 30, 365–373 (1980).

PubMed  Google Scholar 

Korematsu, S. et al. The characterization of cerebrospinal fluid and serum cytokines in patients with Kawasaki disease. Pediatr. Infect. Dis. J. 26, 750–753 (2007).

PubMed  Google Scholar 

Hoshino, S., Tsuda, E. & Yamada, O. Characteristics and fate of systemic artery aneurysm after Kawasaki disease. J. Pediatr. 167, 108–112.e1–2 (2015).

PubMed  Google Scholar 

Dhillon, R. et al. Endothelial dysfunction late after Kawasaki disease. Circulation 94, 2103–2106 (1996).

留言 (0)

沒有登入
gif